TFFP Tff Pharmaceuticals Inc
1,777
$2.17
$0.01
(0.46%)
| Watchers | 1,777 |
| 52-Wk Low | $1.54 |
| 52-Wk High | $15.95 |
| Market Cap | $6.75M |
| Volume | 56,275.00 |
| 52-Wk High | $15.95 |
| 52-Wk Low | $1.54 |
TFF Pharmaceuticals Full Year 2023 Earnings: Misses ExpectationsSimply Wall St • about 2 months ago
TFF Pharmaceuticals ( NASDAQ:TFFP ) Full Year 2023 Results Key Financial Results Net loss: US$21.2m (loss narrowed by...
Share to Feed
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
TFFP stock results show that TFF Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the fourth...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
FORT WORTH, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) ( the Company ), a clinical-stage biopharmaceutical company focused on developing and commercializing...
TFF Pharmaceuticals, Inc. (NASDAQ:TFFP Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest...
Eight of Eight Patients Successfully Transitioned from Oral Tacrolimus to TFF TAC with No Sign of Acute Rejection at Reduced Systemic Exposures Data from TFF VORI Phase 2 and EAP Program Continue to...
Oral Presentation to Present Updated Data from Phase 2 Trial Demonstrating Successful Transition of Patients from Oral Tacrolimus to TFF TACFORT WORTH, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- TFF...
FORT WORTH, Texas, March 22, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the Company or TFF Pharmaceuticals ), a clinical-stage biopharmaceutical company focused on...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
FORT WORTH, March 20, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the Company or TFF Pharmaceuticals ), a clinical-stage biopharmaceutical company focused on developing and...